Direct metal analyses of Mn2+-dependent and -independent protein phosphatase 2A from human erythrocytes detect zinc and iron only in the Mn2+-independent one  by Nishito, Yasumasa et al.
Direct metal analyses of Mn2-dependent and -independent protein
phosphatase 2A from human erythrocytes detect zinc and iron only in the
Mn2-independent one
Yasumasa Nishitoa, Hirofumi Usuia, Kyoko Shinzawa-Itohb, Rintaro Inoue1;a,
Osamu Tanabea, Terumasa Nagase2;a, Takehiko Murakami2;a, Masao Takedaa;*
aDepartment of Biochemistry, Hiroshima University School of Medicine, Kasumi 1-2-3, Minami-ku, Hiroshima 734-8551, Japan
bDepartment of Life Science, Himeji Institute of Technology, Kamigohri Akoh, Hyogo 678-1297, Japan
Received 28 January 1999; received in revised form 12 February 1999
Abstract A Mn2+-dependent protein phosphatase 2A which is
composed of a 34 kDa catalytic CP subunit and a 63 kDa
regulatory AP subunit, was purified from human erythrocyte
cytosol. CP and AP produced V8- and papain-peptide maps
identical to those of the 34 kDa catalytic C and the 63 kDa
regulatory A subunits of the Mn2+-independent conventional
protein phosphatase in human erythrocyte cytosol, respectively.
Reconstitution of CPA and CAP revealed that the metal
dependency resided in CP and not in AP. In CA, 0.87 þ 0.12 mol
zinc and 0.35 þ 0.18 mol iron per mol enzyme were detected by
atomic absorption spectrophotometry, but manganese, magne-
sium and cobalt were not detected. None of these metals was
detected in CPAP. Pre-incubation of CP with ZnCl2 and FeCl2,
but not FeCl3, synergistically stimulated the Mn2+-independent
protein phosphatase activity. The protein phosphatase activity of
C was unaffected by the same zinc and/or iron treatment. These
results suggest that C is a Zn2+- and Fe2+-metalloenzyme and
that CP is the apoenzyme.
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1. Introduction
The reversible phosphorylation of serine/threonine residues
in proteins has been known to play a crucial role in cellular
signal transduction. Protein-serine/threonine phosphatases
(PPs) which catalyze the reverse reaction, have been classi¢ed
into four groups (1, 2A, 2B, 2C) on the basis of the di¡erences
in their biochemical properties [1]. PP1, PP2A and PP2B have
highly homologous catalytic domains but di¡er in their sub-
strate speci¢cities and interactions with regulatory molecules,
whereas PP2C shares no sequence homology to the others [2].
The crystal structures of the catalytic subunits of PP1 [3,4]
and PP2B [5,6] were recently solved. These structures revealed
a common motif of central L-K-L-K-L sca¡old containing a
dinuclear metal ion center located at the active site. Every
active site residue of PP1 and PP2B involved in metal coor-
dination or implicated in catalysis is strictly conserved in
PP2A. Although PP2B has been shown to contain one zinc
atom and one iron atom per catalytic subunit [7], the metals
at the active sites of PP1 and PP2A have not been identi¢ed.
Previously, we puri¢ed three forms of PP2A from human
erythrocyte cytosol, whose subunit structures are CA(K1L1),
CAB(K1L1Q1) and CAB’’(K1L1N1) where C(K) is a 34 kDa cat-
alytic subunit and A(L), B(Q) and B’’(N) are 63, 53 and 74 kDa
regulatory subunits, respectively [8]. Recent molecular cloning
of B’’ [9] has revealed that the subunit has a strong sequence
similarity to the 54 kDa BP regulatory subunit [10^12] in the
central 400 amino acid region and is comprized in the BP
family.
In this paper, in addition to the three Mn2-independent
forms of PP2A, a Mn2-dependent form of PP2A was puri¢ed
from human erythrocyte cytosol. The Mn2-dependent form
was composed of a 34 kDa catalytic CP subunit and a 63 kDa
regulatory AP subunit. V8- and papain-peptide maps of CP
and AP were indistinguishable from those of C and A, respec-
tively. Direct metal analysis by atomic absorption spectropho-
tometry detected stoichiometric zinc and substoichiometric
iron in CA, but no such metals in CPAP. Although PP2A
has been suggested to be a metalloenzyme, this is the ¢rst
demonstration of zinc and iron in PP2A.
2. Materials and methods
2.1. Materials
[Q-32P]ATP and okadaic acid were obtained from Amersham and
Wako, respectively. Other materials were prepared or purchased as
described previously [8,13].
2.2. Phosphatase assay and protein determination
The PP activity was measured [8] in a 50 Wl mixture containing 50
mM HEPES-NaOH, pH 7.4, 0.5 mM dithiothreitol (DTT), 0.01% (v/
v) Triton X-100, 25 mM MnCl2, 250 mM NaCl, 100 WM [32P]H2B
histone phosphorylated by PKA (32P-H2B histone) and an enzyme
preparation (standard assay conditions). Mn2-independent PP2A
was assayed as described [14]. One unit of enzyme was de¢ned as
the amount of enzyme which catalyzed the release of 1 nmol of
[32P]Pi per minute. Protein was determined by the method of Lowry
et al. [15] or Bradford [16].
2.3. Bu¡er solutions
All bu¡er solutions contained 0.5 mM DTT, 0.005% Triton X-100
and protease inhibitors including 0.1 mM phenylmethylsulfonyl £uo-
ride, 1 mM benzamidine, 0.5 mg/l pepstatin, 0.5 mg/l antipain, 1 mg/l
leupeptin and 10 mg/l N-tosyl-L-phenylalanyl chloromethyl ketone. In
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addition to the above constituents, bu¡er A contained 50 mM Tris-
HCl, pH 7.4, 10% (v/v) glycerol and 1 mM EDTA and bu¡er B
contained 20 mM HEPES-NaOH, pH 7.0, 10% glycerol and 1 mM
EDTA.
2.4. Puri¢cation of Mn2 +-dependent PP2A (CPAP)
All procedures were carried out at 0^4‡C. The cytosol fraction
(36 500 U, 217 g protein, 3 l) was prepared from packed human
erythrocytes (700 ml) and was treated with DEAE-Sephadex (110 g
wet weight/1 l cytosol) as described previously [8]. The DEAE-Sepha-
dex fraction (13 400 U, 2.83 g protein, 138 ml) was applied to a
DEAE-Toyopearl column (30U3.2 cm) equilibrated with 0.03 M
NaCl in bu¡er A. The column was washed with 500 ml of the bu¡er
and the enzyme was eluted with a 3.4 l linear 0.03^0.25 M NaCl
gradient in bu¡er A. The £ow rate was 200 ml/h and 18 ml fractions
were collected. Four peaks of PP activity appeared at NaCl concen-
trations of 0.07, 0.11, 0.14 and 0.18 M, as shown in Fig. 1. The
fractions in the third unknown peak indicated by a solid bar in Fig.
1 were pooled and stored at 380‡C. These initial enzyme preparation
steps were repeated three more times. The pooled third unknown
peaks were concentrated with the Pellicon Lab Cassette and an Ami-
con ultra¢ltration cell equipped with a YM-10 membrane. The con-
centrated fraction (8870 U, 228 mg protein, 7.8 ml) was subjected to
gel ¢ltration on a Sephadex G-150 column (80U2.5 cm) equilibrated
with bu¡er A. The active fractions (5610 U, 57.2 mg protein) eluted
from the column were applied to an AH-Sepharose 4B column
(12.5U2.2 cm) equilibrated with 0.1 M NaCl in bu¡er A. The enzyme
was eluted with a 1 l linear 0.1^1.0 M NaCl gradient in bu¡er A at a
£ow rate of 60 ml/h. The active fractions (6790 U, 3.80 mg protein)
eluting at 0.6 M NaCl were concentrated and re-chromatographed on
a Sephadex G-150 column under the same conditions as described
above. The active fractions (6540 U, 1.77 mg protein) were loaded
onto a H1 histone-Toyopearl column (15.8U2.2 cm) equilibrated with
bu¡er A. The enzyme was eluted at a £ow rate of 90 ml/h with a 1.2 l
linear 0^0.5 M NaCl gradient in bu¡er A. The active fractions (4280
U, 1.02 mg protein) eluting at 0.24 M NaCl were concentrated and
subjected to gel ¢ltration on a TSK G3000SW column (60U2.15 cm)
equilibrated with 0.3 M NaCl in bu¡er B at a £ow rate of 1.0 ml/min,
using a Tosoh HPLC system. The pooled active fractions (3630 U,
0.679 mg protein) were concentrated, desalted by ultra¢ltration and
stored at 380‡C.
2.5. Puri¢cation of Mn2-independent PP2A (CA)
Puri¢cation of CA was performed using bu¡er solution without
EDTA. The preparation of the cytosol, chromatography on DEAE-
Sephadex and DEAE-Toyopearl were performed as described above.
The active fractions (11 400 units, 363 mg protein) eluting at 0.18 M
NaCl from a DEAE-Toyopearl column were concentrated and ap-
plied to an AH-Sepharose 4B column (17U1.5 cm) equilibrated
with 0.25 M NaCl in bu¡er A. The column was washed with 60 ml
of the bu¡er and the enzyme was eluted at a £ow rate of 50 ml/h with
a 700 ml linear 0.25^1.2 M NaCl gradient in the bu¡er. The active
fractions (4980 U, 46.8 mg protein, 75 ml) eluting at 0.47 M NaCl
were dialyzed against 2 l of the same bu¡er for 6 h and loaded onto
an H1 histone-Toyopearl column (4.0U1.5 cm) equilibrated with
0.1 M NaCl in bu¡er A. The column was washed with 20 ml of the
bu¡er and the enzyme was eluted at a £ow rate of 10 ml/h with a
140 ml linear 0.1^0.4 M NaCl gradient in the bu¡er. The active frac-
tions (3550 U, 9.99 mg protein, 22 ml) eluting at 0.15 M NaCl were
mixed with 12 ml of bu¡er A and re-chromatographed on an H1
histone-Toyopearl column. The active fractions (2910 U, 3.71 mg
protein) eluting at 0.19 M NaCl were subjected to a protamine-Toyo-
pearl column (4.0U1.5 cm) equilibrated with 0.1 M NaCl in bu¡er A.
The column was washed with 20 ml of the bu¡er and the enzyme was
eluted at a £ow rate of 20 ml/h with a 300 ml linear 0.1^1.5 M NaCl
gradient in the bu¡er. The active fractions eluting at 0.8 M NaCl were
concentrated and desalted by ultra¢ltration. The puri¢ed enzyme had
a speci¢c activity of 1530 U/mg protein, nearly equivalent to that of
enzyme puri¢ed in the presence of 1 mM EDTA as described previ-
ously [8], and was stored at 380‡C.
2.6. Preparation of C, CP, A and AP
4.1 Volumes (v/v) of ice-cold 99.5% (v/v) ethanol were added to CA
(629 Wg, 1.0 ml) or CPAP (57 Wg, 0.2 ml) on ice. After standing for
5 min, the precipitate was collected by centrifugation at 15 000Ug for
10 min at 4‡C. C and CP were extracted from the precipitate with
bu¡er A without EDTA by homogenization with a Dounce homog-
enizer followed by centrifugation. The supernatant was dialyzed
against the bu¡er and stored at 380‡C. A and AP were prepared by
treatment of CA or CPAP (60 Wg) with 6 M urea in 1 ml of bu¡er A
without EDTA, followed by gel ¢ltration on a Superdex 200 column
(118U1.0 cm) equipped with a continuous £ow counter current dia-
lyzing apparatus for the removal of urea as described [17]. The puri-
¢ed A and AP migrated as a single 63 kDa protein band on SDS-
PAGE, respectively, and were stored at 380‡C.
2.7. Metal analysis
The enzymes (CPAP or CA, 0.10 ml, 0.10^0.38 mg/ml) in Te£on
beakers were wet ashed with sulfuric acid, nitric acid and hydrogen
peroxide [18]. Metal contents were determined by atomic absorption
spectrophotometry using a Hitachi model Z8000 spectrophotometer.
3. Results and discussion
When human erythrocyte cytosol was applied to column
chromatography on DEAE-Toyopearl, the PP activity toward
P-H2B histone was eluted into four peaks as shown in Fig. 1.
Three di¡erent forms of PP2A in the ¢rst, second and fourth
peak were separately puri¢ed and their subunit structures
were determined to be CAB’’, CAB and CA, respectively
[8]. The protein phosphatase in the third peak designated un-
known in Fig. 1 was puri¢ed by successive column chroma-
tographies on Sephadex G-150, AH-Sepharose, H1 histone-
Toyopearl and TSK G3000SW. The puri¢ed unknown phos-
phatase had a speci¢c activity of 5340 U/mg protein and was
puri¢ed 17 000-fold from the cytosol fraction with an overall
yield of 1.8%. On non-denaturing PAGE, the puri¢ed enzyme
migrated as one main protein band, which corresponded to
PP activity (data not shown).
The puri¢ed unknown phosphatase preferentially dephos-
phorylated the K subunit of phosphorylase kinase, which
was phosphorylated at both the K and L subunits by
cAMP-dependent protein kinase (PKA). In addition, phos-
phorylase phosphatase activity of the unknown phosphatase
was una¡ected by inhibitor 2 under the conditions in which
the activity of rabbit skeletal muscle PP1 was strongly inhib-
ited (data not shown). Furthermore, the enzyme was very
sensitive to okadaic acid. Using phosphorylase a as substrate,
the IC50 value of okadaic acid for the unknown phosphatase
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Fig. 1. DEAE-Toyopearl elution pro¢le of P-H2B histone phospha-
tase activity in human erythrocyte cytosol. The column chromatog-
raphy, and assays for P-H2B histone phosphatase activity (b) and
for protein (W) were performed as described under Section 2.
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was 8.2 nM. These results classify the puri¢ed phosphatase
into PP2A.
The Stokes radius of the puri¢ed PP2A was determined by
gel ¢ltration on Sephadex G-150 to be 4.2 þ 0.1 (mean þ
S.E.M., n = 3) nm. The s20;w value of the enzyme was meas-
ured by sucrose density gradient centrifugation analysis to be
5.7 þ 0.1 (mean þ S.E.M., n = 3) S. From these parameters, the
apparent molecular weight of the puri¢ed PP2A was calcu-
lated to be 103 000 as described [19].
The SDS-PAGE of the puri¢ed enzyme yielded two Coo-
massie blue stained bands of 63 and 34 kDa and were tenta-
tively referred to as AP and CP, respectively (Fig. 2A). The 34
kDa CP subunit had the same mobility on SDS-PAGE and
displayed the same V8- and papain-peptide maps as those of
the 34 kDa catalytic C subunit of conventional Mn2-inde-
pendent PP2A (Fig. 2A and B). Likewise, the 63 kDa AP
subunit showed the same mobility on SDS-PAGE and the
same peptide maps as those of the 63 kDa regulatory A sub-
unit of conventional PP2A (Fig. 2A and B). Assuming that
Coomassie blue staining of each subunit was equal, the molar
ratio of CP and AP estimated from the densitometric scan of
the stained gel was 1.00: 0.97. The sum of the molecular
masses of CP and AP was in good agreement with the molec-
ular weight of 103 000 for the puri¢ed enzyme, indicating that
the subunit structure of the puri¢ed PP2A was CPAP.
Although the physicochemical properties of CPAP so far
tested were indistinguishable from those of CA, the metal
requirement of CPAP was clearly distinct from that of CA.
Mn2 was essential for the P-H2B histone phosphatase activ-
ity of CPAP (Fig. 3A). Mn2 could not be replaced by Mg2
(Fig. 3A). By contrast, CA, the conventional PP2A showed
the intrinsic PP activity without Mn2 (Fig. 3B). The intrinsic
PP activity was stimulated by Mn2 or Mg2 (Fig. 3B). The
Mn2 requirement for CPAP activity was also observed when
phosphorylase a, phosphorylase kinase a and P-H1 histone
were used as substrates (data not shown).
To know whether the Mn2 requirement for CPAP activity is
attributable to the catalytic subunit CP or the regulatory sub-
unit AP or both, CP was isolated by treatment of CPAP with
80% ethanol [22]. CP thus obtained showed a Mn2 require-
ment for activity as observed with CPAP (Fig. 3A). On the
other hand, the catalytic subunit C prepared by the 80% etha-
nol treatment of CA, showed Mn2 and Mg2 curves similar
to those of CA (Fig. 3B). However, the optimal concentra-
tions of Mn2 and Mg2 for CP and C were lower than those
for CPAP and CA, respectively (Fig. 3). To test the e¡ect of the
regulatory subunits AP and A on the divalent cation require-
ment of CP and C, AP and A were isolated separately by gel
¢ltration of CPAP and CA in the presence of 6 M urea [17].
Reconstruction of heterodimeric forms of PP2A clearly
showed that neither AP nor A had any e¡ect on the Mg2
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Fig. 3. Mn2 and Mg2 requirement for PP activity of CPAP, CP,
CA and C. The rate of Pi release from P-H2B histone was meas-
ured as described under Section 2 except that 250 mM NaCl was
excluded and 25 mM MnCl2 was replaced by the indicated concen-
tration of MnCl2 (b, a) or MgCl2 (R, O). A: CPAP (1.7 U/ml) (b,
R) and CP (1.3 units/ml) (a, O) were used. B: CA (1.3 U/ml) (b,
R) and C (0.58 U/ml) (a, O) were used.
Fig. 2. SDS-PAGE of the unknown phosphatase puri¢ed from hu-
man erythrocytes and peptide maps of the subunits. A: The puri¢ed
unknown phosphatase and CA (1.1 Wg protein each) were applied
to 10% SDS-PAGE and detected by Coomassie blue staining as de-
scribed [8]. B: The stained bands of CP, C, AP and A were cut out
and applied to 15% SDS-PAGE with 0.20 Wg/lane V8 protease or
0.025 Wg/lane papain. Proteolytic digestion was then allowed to take
place for 30 min in the stacking gel as described [20]. After electro-
phoresis, peptide bands were visualized by silver staining [21]. Bo-
vine serum albumin (BSA) (68 kDa), carbonic anhydrase (30 kDa)
and myoglobin (17 kDa) were used as standards.
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and Mn2 requirement of CP and C (Table 1). Reconstruction
of heterodimeric forms of PP2A was con¢rmed by the shift of
the activity peak on Sephadex G-150 gel ¢ltration (data not
shown) and the inhibitory e¡ect of AP and A on the PP ac-
tivity of CP and C (Table 1). These results indicate that the
di¡erence in the divalent cation requirement of the heterodi-
meric forms of PP2A is attributable to the catalytic subunits,
CP and C.
It has been suggested from the predicted primary structure
that the catalytic subunit of PP2A may contain two metal ions
at the active site, possibly zinc and/or iron [23]. To test this
possibility, zinc, iron, manganese, magnesium and cobalt in
CA and CPAP were analyzed by atomic absorption spectro-
photometry. The metal analysis of CA showed that 1 mol CA
contains 0.87 þ 0.12 (mean þ S.E.M., n = 3) mol zinc and
0.35 þ 0.18 (mean þ S.E.M., n = 3) mol iron but no manganese,
cobalt or magnesium. On the other hand, such metals were
not detected in CPAP. These results support the notion that the
catalytic subunit C in the conventional form of PP2A is a
zinc- and iron-metalloenzyme and is transformed into CP by
removal of the metals. PP2B has been shown to contain one
zinc atom and one iron atom per catalytic subunit [7]. The
two-metal active site in the crystal structures of the catalytic
subunits of PP1 [3,4] and PP2B [5,6] explains the function of a
set of highly conserved residues and should lead to the eluci-
dation of the reaction mechanism shared by the structural
family of metallo-phospho-esterases including PP2A and pur-
ple acid phosphatase. The crystal structure of a PP1 catalytic
subunit also showed the surface location of the metal binding
sites suggesting that the metals could be labile, which might
explain why they are di⁄cult to identify biophysically [24].
These results may explain why substoichiometric iron was
detected in CA.
To know whether or not CP is an apoenzyme of C, the e¡ect
of pre-incubation of CP and C with Zn2, Fe2 and Fe3 in
the presence of 1 mM ascorbate on their Mn2-independent
phosphorylase phosphatase activity was investigated (Table
2). The Mn2-independent PP activity of CP was stimulated
2^3-fold by pre-incubation with 5 WM ZnCl2 or 15 WM FeCl2,
but only slightly stimulated by pre-incubation with 15 WM
FeCl3. A synergistic stimulatory e¡ect on the Mn2-independ-
ent PP activity was observed when CP was pre-incubated with
ZnCl2 and FeCl2, but not with ZnCl2 and FeCl3 (Table 2).
The PP activity of Zn2/Fe2-activated CP was 16% of that of
Mn2-activated CP. On the other hand, the same pre-incuba-
tion of C with these metal ions showed no e¡ect on the Mn2-
independent PP activity (Table 2). These results suggest that
C is a Zn2- and Fe2-metalloenzyme and that CP is the apo-
enzyme.
Ingebritsen et al. [25] reported that PP2A in fresh skeletal
muscle or liver extracts was variably stimulated by Mn2.
They further noted that during puri¢cations, PP2A became
more dependent upon Mn2 for its activity. Highly puri¢ed
bovine heart PP2A catalytic subunit lost virtually all of its
activity and became Mn2- or Co2-dependent during storage
at 370‡C for 6 years [26]. Yu [27] also obtained Mn2- and
Co2-dependent PP2A after prolonged storage of PP2A and
observed the activation of the latent form of PP2A by the
addition of Fe2 and reducing agents such as ascorbate or
DTT to the reaction mixture, suggesting that Fe2 could be
a biologically important cofactor responsible for PP2A acti-
vation. These phenomena may also be explained by the notion
that the Mn2-independent catalytic subunit C of PP2A is a
metalloenzyme and converts to Mn2-dependent catalytic sub-
unit CP by removal of the bound metals. Since freshly pre-
pared human erythrocyte cytosol showed the CPAP/CA ratio
in the DEAE-Toyopearl elution pro¢le (Fig. 1) to be 8.1 þ 0.4
(mean þ S.E.M., n = 3)/100 even in the absence of EDTA, the
interconversion of CPAP and CA in the cell may have the
physioligical signi¢cance which remains to be explored.
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